IDEX Corporation closed out 2025 with strong performance in the fourth quarter, driven by record sales and orders, particularly in the Health & Science Technologies segment due to increasing demand for AI-related projects. Despite a challenging demand environment in other segments, the company's strategic execution delivered visible results and improved operational metrics.

IDEX Corporation reported strong second-quarter 2025 results with record sales of $865.4 million, a 7% increase year-over-year, and adjusted diluted EPS of $2.07, which was relatively flat but exceeded expectations. The company experienced a slight downshift in rapid-turn business orders and a more cautious stance from customers on larger orders, leading to a revised full-year EPS outlook. Despite near-term volatility, IDEX remains confident in its long-term value creation strategy.

IDEX delivered Q1 2025 revenue growth driven by acquisitions, but net income and EPS declined due to restructuring expenses and higher costs.

IDEX Corporation reported a strong fourth quarter with record sales of $863 million, a 9% increase overall and 3% organically. The company's diluted EPS rose by 13% to $1.62, and adjusted diluted EPS increased by 11% to $2.04. Growth was driven by acquisitions and positive returns in fire safety and diversified products, while the health & science technologies segment showed strong organic orders growth.

IDEX Corporation reported a 1% increase in sales to $798 million, while organic sales remained flat. Reported EPS decreased 43% to $1.57, and adjusted EPS decreased 10% to $1.90. The company completed the acquisition of Mott Corporation and updated its full-year outlook.

IDEX Corporation reported a 5% decrease in sales to $807 million, with a 4% organic decline. Reported diluted EPS increased by 2% to $1.86, while adjusted diluted EPS decreased by 6% to $2.06. The company's performance exceeded expectations despite macroeconomic headwinds, with margin expansion achieved through strong execution.

IDEX Corporation reported first-quarter sales of $801 million, a 5% decrease overall and a 6% organic decline, aligning with expectations. Despite the sales decrease, the company's adjusted diluted EPS of $1.88 exceeded expectations. Strong operating cash flow of $157 million, up 6%, and free cash flow of $137 million, up 13%, were also reported. The company confirmed its full-year guidance.

IDEX Corporation reported a 3% decrease in sales to $789 million and a 16% decrease in reported diluted EPS to $1.43 for the fourth quarter of 2023. However, the company highlighted strong operating cash flow of $201 million, a 20% increase, and free cash flow of $179 million, a 22% increase.

IDEX Corporation reported Q3 2023 results with sales of $793.4 million, a decrease of 4% overall and 6% organically. Diluted EPS was $2.75, up 17%, and adjusted diluted EPS was $2.12, down 1%. The company raised its full-year GAAP EPS guidance to $7.91 to $7.96 and adjusted EPS guidance to $8.13 to $8.18.

IDEX Corporation reported record second-quarter results with sales of $846.2 million, up 6% overall and 3% organically. The company reported EPS of $1.82, up 1% and record adjusted EPS of $2.18, up 8%. They are lowering full year guidance in response to softening second half outlook.

IDEX Corporation reported record sales of $845 million, a 13% increase overall and 6% organically. Reported EPS was $1.84, up 1%, and adjusted EPS was $2.09, up 7%. Strong operating cash flow of $148 million, up 86%, resulted in free cash flow of $121 million, up 91%. The company reached an agreement to purchase Iridian Spectral Technologies in April 2023.

IDEX Corporation reported a strong fourth quarter with sales of $810.7 million, up 13% overall and 12% organically, and EPS of $1.71, up 10% and adjusted EPS of $2.01, up 18%. Net income increased to $130.0 million. The company achieved record full-year results, driven by capacity expansion, innovation, and strategic acquisitions.

IDEX Corporation reported record third-quarter results, with sales of $824 million, a 16% increase compared to the prior year period. Record reported EPS was $2.36, up 56% and record adjusted EPS was $2.14, up 20% vs. Q3 2021. The company raised its full-year GAAP EPS and adjusted EPS guidance to $7.75 to $7.80 and $8.04 to $8.09, respectively.

IDEX Corporation reported strong second-quarter results with a 16% increase in sales, driven by 12% organic growth. The company achieved record adjusted EPS of $2.02, a 15% increase year-over-year. Operating margin performance remained strong, and the company completed the acquisition of KZValve.

IDEX Corporation reported record first-quarter results, with record sales of $751 million, up 15% overall and 12% organically. The company also achieved record EPS of $1.83, up 24%, and record adjusted EPS of $1.96, up 21% compared to Q1 2021.

IDEX Corporation reported record fourth-quarter sales of $714.8 million, up 16% overall and 11% organically. Reported and adjusted EPS were both $1.55. The company anticipates continued supply chain challenges and COVID-19 impacts in the first half of 2022 but remains optimistic about long-term growth.

IDEX Corporation announced record third-quarter results with significant increases in orders and sales. The company reported a 23% increase in sales and a 36% increase in orders compared to the prior year. Adjusted EPS reached a record $1.63, and the company narrowed its full-year adjusted EPS guidance to $6.30 to $6.33.

IDEX Corporation reported record orders and sales in Q2 2021, with orders reaching $751.0 million and sales at $685.9 million. The company's adjusted EPS was $1.61, and full-year adjusted EPS guidance was raised to $6.26 to $6.36. IDEX finalized the termination of the U.S. pension plan, refinanced senior notes, and completed the acquisition of Airtech Group, Inc.

IDEX Corporation reported a 10% increase in both orders and sales for Q1 2021, with organic growth of 6%. The company's reported EPS was $1.48, with an adjusted EPS of $1.51. Strong cash generation led to a record Q1 free cash flow of $94.7 million. The company raised its full year adjusted EPS guidance to $6.05 to $6.20.

IDEX Corporation reported a strong fourth quarter in 2020, with record orders driven by improvements in most end markets and positive organic order growth across all segments. The company's adjusted EPS increased by 3% and free cash flow increased by 9% compared to the prior year period.

IDEX Corporation announced its financial results for the three month period ended September 30, 2020. Sales were $581.1 million, down 7 percent compared with the prior year period. Adjusted EPS was $1.40.

IDEX Corporation reported a decrease in sales and earnings for the second quarter of 2020, impacted by the global health pandemic. However, the company demonstrated resilience with strong operating performance and the development of new products to support the fight against COVID-19. The company achieved record quarterly free cash flow and ended the quarter with a strong cash position.

IDEX Corporation reported a decrease in sales by 4% and EPS by 8% compared to the prior year period. However, the company increased its backlog by $50 million and expanded gross margins. Due to the uncertain impact of the COVID-19 pandemic, IDEX withdrew its prior financial guidance and suspended future guidance for the rest of the year.

IDEX Corporation reported a slight decrease in sales for the fourth quarter of 2019, with a corresponding decrease in gross margin. Operating income also decreased, but adjusted operating income remained flat compared to the prior year period. The company executed a restructuring plan to mitigate the impact of market softness, and announced an agreement to acquire Flow Management Devices LLC.